Formulation and clinical evaluation of a hydrocortisone solution for the treatment of oral disease

International Journal of Pharmaceutics

Volumn 139, Issue 1-2, 1996, Pages 63-68

  Kristmundottir T ^a   Loftsson, T ^a   Holbrook, W P ^a  

^a UNIVERSITY OF ICELAND   (Iceland)

Author keywords

2 Hydroxypropyl cyclodextrin; Clinical evaluation; Hydrocortisone; Oral disease

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; BENZALKONIUM CHLORIDE; EDETATE SODIUM; HYDROCORTISONE; METHYL PARABEN; PRESERVATIVE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPLEX FORMATION; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG SOLUBILITY; DRUG STABILITY; HUMAN; MOUTH DISEASE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0030576545     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(96)04565-6     Document Type: Article

References (16)

1. Bottomley, W.K. and Rosenberg, S.W., Clinician's guide to treatment of common oral conditions, 3rd ed., The American Academy of Oral Medicine, New York, 1993, pp. 15-18.
2. Holbrook, W.P., Kristmundsdóttir, T., Sveinsson, S.J. and Loftsson, T., Improved topical steroids for oral use: development and preliminary clinical observations. J. Dent. Res., 73 (1994) 964 abstract no. 206.
3. Loftsson, T., Brewster, M.E., Derendorf, H. and Bodor, N., 2-Hydroxypropyl-β-cyclodextrin: Properties and usage in pharmaceutical formulations. Pharm. Ztg. Wiss., 4/136 (1991a) 5-10.
4. Loftsson, T., Ölafsdöttir, B.J. and Bodor, N., The effects of cyclodextrins on transdermal delivery of drugs. Eur. J. Pharm. Biopharm., 37 (1991b) 30-33.
5. Loftsson, T., Stefánsdóttir, Ö., Fridriksdöttir, H. and Gudmundsson, Ö., Interactions between preservatives and 2-hydroxypropyl-β-cyclodextrin. Drug Dev. Ind. Pharm., 18(13) (1992) 1477-1484.
6. Loftsson, T. and Bodor, N., Effect of cyclodextrins on percutaneous transport of drugs. In Smith, W. and Maibach, H.I. (Ed.) Percutaneous Penetration Enhancers, CRC Press, 1995, pp. 335-342.
7. Møllgaard Andersen, F. and Bundgaard, H., The influence of β-cyclodextrin on the stability of hydrocortisone in aqueous solution. Arch. Pharm. Chem. Sci. Ed., 11 (1983) 61-66.
8. Oliver, G.F. and Winkelmann, R.K. Treatment of Lichen Planus. Drugs, 45(1) (1993) 56-65.
9. Pitha, J., Milecki, J., Fales, H., Pannell, L. and Uekama, K., Hydroxypropyl-β-cyclodextrin: Preparation and Characterization; effects on solubility of drugs. Int. J. Pharm., 29 (1986) 73-82.
10. Rödström, P.-O., Nordin, P., Hakeberg, M. and Jontell, M., Treatment of oral lichen planus by topical application of Clobetasol Propionate (Dermovate) in Orabase. J. Dental Research, 72 (1992) abstract no. 1123.
11. Seymour, R.A., Oral and dental disorders. Pharm. J., 252 (1994) 777-782.
12. Sigurdardóttir, A.M. and Loftsson, T., The effect of polyvinylpyrrolidone on cyclodextrin complexation of hydrocortisone and its diffusion through hairless mouse skin. Int. J. Pharm., 126 (1995) 73-78.
13. Szejtli, J., Cyclodextrin Technology, Kluwer, Dordrecht, 1988.
14. Yoshida, A., Arima, H., Uekama, K. and Pitha, J., Pharmaceutical evaluation of hydroxyalkylesters of β-cyclodextrin. Int. J. Pharm., 46 (1988) 217-222.
15. Zegarelli, D.J., Multimodality steroid therapy of erosive and ulcerative oral lichen planus. J. Oral Med., 38 (1983) 127-130.
16. Zegarelli, D.J., Mouthwashes in the treatment of oral disease. Drugs, 42(2) (1991) 171-173.